"We are clinical pharmacologists and drug developers with innate ability to aid in solving drug development challenges and developing straight forward strategies for successful therapies."

Preparing pharmacy graduates for traditional and emerging career opportunities.

Authors: Gayle A Brazeau, Susan M Meyer, Michele Belsey, Edward M Bednarczyk, Sanela Bilic, Julie Bullock, Gary E DeLander, E F Fiese, Stephen L Giroux, Danny McNatty, Ruth Nemire, William A Prescott, Andrew P Traynor
Am J Pharm Educ 2009 Dec;73(8):157
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, NY, USA.
December 2009

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study.

Authors: Andrew Spencer, Andrew Roberts, Nola Kennedy, Christina Ravera, Serge Cremers, Sanela Bilic, Terry Neeman, Michael Copeman, Horst Schran, Kevin Lynch
BMC Clin Pharmacol 2008 Mar 31;8. Epub 2008 Mar 31.
Department of Haematology and Bone Marrow Transplantation, The Alfred Hospital, Prahan, Victoria, Australia.
March 2008

Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.

Authors: Olanrewaju Okusanya, Alan Forrest, Robin DiFrancesco, Sanela Bilic, Susan Rosenkranz, Michael F Para, Elizabeth Adams, Kevin E Yarasheski, Richard C Reichman, Gene D Morse,
Antimicrob Agents Chemother 2007 May 5;51(5):1822-6. Epub 2007 Feb 5.
Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 317 Hochstetter Hall, Amherst, NY 14260, USA.
May 2007

Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.

Authors: Heather A Huet, Joseph D Growney, Jennifer A Johnson, Jing Li, Sanela Bilic, Lance Ostrom, Mohammad Zafari, Colleen Kowal, Guizhi Yang, Axelle Royo, Michael Jensen, Bruno Dombrecht, Kris R A Meerschaert, Joost A Kolkman, Karen D Cromie, Rebecca Mosher, Hui Gao, Alwin Schuller, Randi Isaacs, William R Sellers, Seth A Ettenberg
MAbs 2014 ;6(6):1560-70
a Oncology Research; Novartis Institutes for Biomedical Research ; Cambridge , MA USA.

New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats.

Authors: Markus Walles, Bettina Rudolph, Thierry Wolf, Julien Bourgailh, Martina Suetterlin, Thomas Moenius, Gisela Peraus, Olivier Heudi, Walid Elbast, Christian Lanshoeft, Sanela Bilic
Drug Metab Dispos 2016 07 27;44(7):897-910. Epub 2016 Apr 27.
Novartis Institutes for Biomedical Research, Drug Metabolism and Pharmacokinetics, Basel, Switzerland (M.W, B.R., T.W., J.B., M.S., T.M., G.P., O.H., W.E., C.L.); and Translational Clinical Oncology, East Hannover, New Jersey (S.B.).

Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers.

Authors: Carl U Bialucha, Scott D Collins, Xiao Li, Parmita Saxena, Xiamei Zhang, Clemens Dürr, Bruno Lafont, Pierric Prieur, Yeonju Shim, Rebecca Mosher, David Lee, Lance Ostrom, Tiancen Hu, Sanela Bilic, Ivana Liric Rajlic, Vladimir Capka, Wei Jiang, Joel P Wagner, GiNell Elliott, Artur Veloso, Jessica C Piel, Meghan M Flaherty, Keith G Mansfield, Emily K Meseck, Tina Rubic-Schneider, Anne Serdakowski London, William R Tschantz, Markus Kurz, Duc Nguyen, Aaron Bourret, Matthew J Meyer, Jason E Faris, Mary J Janatpour, Vivien W Chan, Nicholas C Yoder, Kalli C Catcott, Molly A McShea, Xiuxia Sun, Hui Gao, Juliet Williams, Francesco Hofmann, Jeffrey A Engelman, Seth A Ettenberg, William R Sellers, Emma Lees
Cancer Discov 2017 09 19;7(9):1030-1045. Epub 2017 May 19.
Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.